Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,238.9
7.0 (0.22%)

 

  • STI Straits Times Index
    3,238.9
    7.0 (0.22%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,594.8
    1.2 (0.08%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,326.7
    3.0 (0.01%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,891.3
    -18.5 (-0.64%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,303.3
    161.8 (0.70%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,128.3
    29.4 (0.48%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,162.2
    22.9 (1.07%)
    Index delayed 20 minutes
  • XAO XAO
    6,898.9
    58.1 (0.85%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,681.9M
  • Value: 1,310.8M
  • Rise: 177
  • Fall: 153
  • Unch: 499

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
SinoCloud0.001-
United Engineers2.700-0.010
YZJ Shipbldg SGD1.000+0.030
SingTel3.180-0.120
Golden Agri-Res0.255+0.010
Rex Intl0.191-0.007
China Star Food0.030+0.002
Tritech0.032+0.003
Ascendas Reit2.890-0.010
Sino Grandness0.044-

World Indices

World Indices
Name Last Change
Nasdaq 8,540.8 +61.8
HSI 26,326.7 +3.0
HSCEI 10,424.8 -2.6
Jakarta 6,128.3 +29.4
Nikkei 225 23,303.3 +161.8
SSE Comp 2,891.3 -18.5
Shanghai A 3,029.3 -19.4
Shanghai B 255.2 -3.0
PSE Comp 0.0
KOSPI 2,162.2 +22.9

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CARA THERAPEUTICS INC CARA THERAPEUTICS
Updated on 15 Nov 2019 (End of trading day)
Last (USD): 21.160 Change: -0.280 High: 22.050 Remarks: -
Change (%): -1.31 Low: 21.120
Open 21.480 Yesterday's Close 21.44
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 385,607 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.58557 Trailing EPS (USD) e -2.10831 NAV (USD) b 4.5394
PE a - Trailing PE f - Price / NAV b 4.6614
Dividend (USD) d - Cash In Hand (USD) g 0.7435 Issued & Paid-up Shares c 46,679,000
Dividend Yield (%) d - Price / Cash In Hand g 28.460 Treasury Shares h -
Beta - 75 Daysi 0.089 R-Squared - 75 Days(%)i 0.19 Market Cap (M) 987.728
Beta - 500 Daysi 0.066 R-Squared - 500 Days (%)i 0.04 Enterprise Value (M) 799.186
Piotroski F Score 2 Exchange Code CARA Par Value ( $ ) n.a.
52 Weeks Volatility (%) 47.13 Free Float (%) 90.7
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 07 Nov 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CARA THERAPEUTICS INC NASDAQ 987.728 - - 4.6614 -
Industry Biotechnology NASDAQ 2,373.581 139.559 145.316 5.4669 0.734
Local Peer AMGEN INC NASDAQ 131,231.478 15.634 16.268 12.0099 2.533
Local Peer GILEAD SCIENCES INC NASDAQ 82,323.311 15.091 30.569 3.9955 3.551
Local Peer CELGENE CORP NASDAQ 78,302.774 19.353 13.317 6.4783 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 53,950.070 25.735 25.166 10.2696 -
Local Peer BIOGEN INC NASDAQ 50,933.363 11.496 9.440 3.6392 -
Local Peer ILLUMINA INC NASDAQ 44,979.795 54.455 46.228 10.1329 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 37,865.336 15.491 17.659 3.6047 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 23,981.306 309.037 16.310 2.3132 -
Local Peer SEATTLE GENETICS INC NASDAQ 19,666.543 - - 11.0511 -
Local Peer INCYTE CORPORATION NASDAQ 18,674.920 170.558 46.115 7.7089 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 13,479.060 - - 4.3843 -
Local Peer EXACT SCIENCES CORP NASDAQ 12,080.386 - - 16.1443 -
Other Local Peers BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), MODERNA INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), REPLIGEN CORP (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ALKERMES PLC (NASDAQ), FIBROGEN INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NATERA INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), ACCELERON PHARMA (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), XENCOR INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), INSMED INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), VIELA BIO INC (NASDAQ), EPIZYME INC (NASDAQ), REGENXBIO INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), VERACYTE INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), FATE THERAPEUTICS (NASDAQ), RADIUS HEALTH INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), OPKO HEALTH INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), INTREXON CORP (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), NEXTCURE INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), OMEROS CORP (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), TRANSLATE BIO INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), RETROPHIN INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), CHEMOCENTRYX INC (NASDAQ), XBIOTECH INC (NASDAQ), AGENUS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), SYNTHORX INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), CYTOKINETICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), MORPHIC HOLDING INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MERUS B V (NASDAQ), MACROGENICS INC (NASDAQ), AVROBIO INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), DERMIRA INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), RECRO PHARMA INC (NASDAQ), ARDELYX INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), COMPUGEN (NASDAQ), MEDICINOVA INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), PERSONALIS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ANAPTYSBIO INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), GLYCOMIMETICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), GERON CORP (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), MANNKIND CORPORATION (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), KAMADA (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), XOMA CORP (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), ATHERSYS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), CHIASMA INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), CUE BIOPHARMA INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), IVERIC BIO INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), IMV INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), SESEN BIO INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), CHIMERIX INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), NANTKWEST INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), VBI VACCINES INC CDA (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), COHBAR INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), VERMILLION INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ARAVIVE INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), OTONOMY INC (NASDAQ), VACCINEX INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), SYNLOGIC INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), VERASTEM INC (NASDAQ), TREVENA INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), EQUILLIUM INC (NASDAQ), INFLARX N V (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), CURIS INC (NASDAQ), INMUNE BIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), RESTORBIO INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), ZAFGEN INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SOLIGENIX INC (NASDAQ), SENESTECH INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), VAXART INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), SOPHIRIS BIO INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), TOCAGEN INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIOCEPT INC (NASDAQ), PRECIPIO INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), TROVAGENE INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 20 ORD SHS (NASDAQ), ADVAXIS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), OCUGEN INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), SPHERIX INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), OPGEN INC (NASDAQ)
Global Peer CSL ASX 124,695.694 46.478 46.478 16.6635 0.966
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer AGILENT TECHNOLOGIES INC NYSE 24,218.966 76.642 22.592 5.1020 0.783
Global Peer SINO BIOPHARM HKEx 140,338.934 13.097 13.517 4.1230 0.656
Global Peer WUXI BIO HKEx 109,791.155 146.993 114.916 11.3016 -
Global Peer BEIGENE HKEx 98,300.404 - - - -
Global Peer Lonza SGX 5,937.453 7.663 9.330 0.6935 4.766
Global Peer GENSCRIPT BIO HKEx 33,542.820 201.726 - 9.4592 -
Global Peer 3SBIO HKEx 31,698.826 20.954 25.505 3.1243 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 2,830.028 45.136 658.146 2.7343 -
Other Global Peers HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), CKLIFE SCIENCES (HKEx), POLYNOVO LIMITED (ASX), VIVA BIOTECH (HKEx), ASCENTAGE-B (HKEx), AVITA MEDICAL LTD (ASX), MESOBLAST LTD (ASX), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), MYOVANT SCIENCES LTD (NYSE), KADMON HLDGS INC (NYSE), ESSEX BIO-TECH (HKEx), ARCUS BIOSCIENCES INC (NYSE), STARPHARMA HOLDINGS LIMITED (ASX), LEE'S PHARM (HKEx), TELIX PHARMACEUTIC (ASX), NEXT SCIENCE LTD (ASX), DPHARMA (Bursa), PFENEX INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), BBI LIFE SCI (HKEx), 22ND CENTURY GROUP INC (NYSE American), ENZO BIOCHEM INC (NYSE), NANOVIRICIDES INC (NYSE American), UNI-BIO GROUP (HKEx), LINEAGE CELL THERAPEUTICS INC (NYSE American), RESAPP HEALTH LIMITED (ASX), PALATIN TECHNOLOGIES INC (NYSE American), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), IMUGENE LIMITED (ASX), PHYLOGICA LIMITED (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), CYNATA THERAPEUTICS LTD (ASX), ONCOSIL MEDICAL LIMITED (ASX), IMMUTEP LTD (ASX), CEL-SCI CORP (NYSE American), ORTHOCELL LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), CT ENTERPRISE (HKEx), PORT (SET), ARMATA PHARMACEUTICALS INC (NYSE American), BIONOMICS LTD (ASX), NOVITA HEALTHCARE LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), REGENT PACIFIC (HKEx), BIOTRON (ASX), INVEX THERAPEUTICS LTD NPV (ASX), BIOSINO BIO-TEC (HKEx), MEMPHASYS LTD (ASX), RHINOMED LIMITED (ASX), ORAGENICS INC (NYSE American), INDIA GLOBALIZATION CAPITAL INC (NYSE American), EXTRAWELL PHAR (HKEx), ISORAY INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), ANTEOTECH LIMITED (ASX), PROTEOMICS INTL LABORATORIES LTD (ASX), IMMURON LIMITED (ASX), CELLMID LIMITED (ASX), PATRYS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), Suntar Eco-City^ (SGX), IBIO INC (NYSE American), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ADALTA LTD (ASX), GENETIC TECHNOLOGIES (ASX), REGENEUS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), BENITEC BIOPHARMA LTD (ASX), MEGASUN (Bursa), CCP TECHNOLOGIES LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), HAO WEN HLDGS (HKEx), BIOXYNE LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), MGRC (Bursa), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), TBG DIAGNOSTICS LTD (ASX), QT Vascular (SGX), MEDIBIO LIMITED (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AIM IMMUNOTECH INC (NYSE American), NANOLLOSE LTD (ASX), BPH ENERGY LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.020
-0.09 %
10 Days -+0.010
+0.05 %
20 Days -+2.030
+10.61 %
Medium Term Return 3 Months --2.190
-9.38 %
6 Months -+2.130
+11.19 %
1 Year -+2.120
+11.13 %
Long Term Return 2 Years -+8.980
+73.73 %
3 Years -+9.190
+76.78 %
5 Years -+12.205
+136.29 %
Annualised Return Annualised --
+18.77 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 12.190 - 27.550 Change From 1 Year Low +8.970 % Change From 1 Year Low (%) +73.58
Change From 1 Year High -6.390 % Change From 1 Year High (%) -23.19
2 Years Range 11.460 - 27.550 Change From 2 Years Low +9.700 % Change From 2 Years Low (%) +84.64
Change From 2 Years High -6.390 % Change From 2 Years High (%) -23.19
5 Years Range 4.260 - 28.500 Change From 5 Years Low +16.900 % Change From 5 Years Low (%) +396.71
Change From 5 Years High -7.340 % Change From 5 Years High (%) -25.75
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

CARA Therapeutics, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frédérique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.

Historical Price Data

Date Open High Low Close Volume VWAP
15 Nov 2019 21.480 22.050 21.120 21.160 385,607 -
14 Nov 2019 21.280 21.510 21.050 21.440 264,082 -
13 Nov 2019 21.450 21.650 21.110 21.430 268,217 -
12 Nov 2019 21.290 21.800 21.250 21.690 456,119 -
11 Nov 2019 21.280 21.380 20.810 21.270 413,601 -
08 Nov 2019 20.650 21.340 20.582 21.180 602,991 -
07 Nov 2019 19.550 20.700 19.500 20.680 377,419 -
06 Nov 2019 20.210 20.480 18.590 19.410 598,921 -
05 Nov 2019 20.430 20.952 20.230 20.740 348,860 -
04 Nov 2019 21.370 21.480 20.260 20.380 545,931 -
01 Nov 2019 20.680 21.280 20.616 21.150 383,621 -
31 Oct 2019 20.350 20.780 20.180 20.760 351,006 -
30 Oct 2019 20.350 20.455 20.240 20.350 229,140 -
29 Oct 2019 20.260 20.520 20.220 20.360 240,065 -
28 Oct 2019 20.300 20.600 20.100 20.250 272,793 -
25 Oct 2019 19.920 20.285 19.601 20.060 294,374 -
24 Oct 2019 19.640 19.980 19.410 19.880 398,481 -
23 Oct 2019 19.270 19.870 19.180 19.560 352,173 -
22 Oct 2019 19.540 19.790 19.300 19.330 395,908 -
21 Oct 2019 19.380 19.600 19.130 19.445 299,221 -
18 Oct 2019 19.600 19.610 18.950 19.130 396,528 -
17 Oct 2019 19.370 19.780 19.230 19.690 298,007 -
Summary
Current 2 Weeks
(04 Nov 2019 to 15 Nov 2019)
21.370 22.050 18.590 21.160 4,261,748 -
Previous 2 Weeks
(21 Oct 2019 to 01 Nov 2019)
19.380 22.050 18.590 21.150 3,216,782 -
4 Weeks from
(23 Sep 2019 to 18 Oct 2019)
22.250 22.580 18.590 19.130 11,935,627 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.